R1 RCM Inc

R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Murray, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

R1 RCM Inc (RCM) posts strong Q4 results, eyes Cloudmed growth

R1 RCM Inc (RCM) delivered robust financial performance in Q4 2022, focusing on operational excellence, technology investments, and customer engagement. Challenges include integration efforts and seasonality affecting incentive fees. The company is poised for growth with opportunities in Cloudmed expansion and AI utilization.

R1 RCM Inc (RCM) reports strong Q1 results and growth opportunities

R1 RCM Inc (RCM) delivered strong Q1 results, with a focus on operational improvements, robust Cloudmed growth, and positive financial outlook for 2023.
The company showcased resilience in stable patient self-pay trends, improving payer reimbursement timelines, and strategic capacity for onboarding new NPR, positioning itself for continued success.
Challenges include industry financial pressures, sustaining growth in legacy business, and managing operational costs effectively, requiring strategic adaptation and continuous innovation.
Opportunities lie in pipeline visibility for deals, sequential EBITDA growth, integration of Cloudmed capabilities, and strategic onboarding plans, offering avenues for expansion and profitability.

R1 RCM Inc reports robust Q2 earnings, eyes growth opportunities

R1 RCM Inc's Q2 performance was strong, with a focus on technology and operational enhancements. Challenges include revenue adjustments and workforce implications of automation. Opportunities lie in improved payer dynamics and growth through physician market focus and cross-selling.

R1 RCM Inc reports robust Q3 performance and eyes growth

R1 RCM Inc's Q3 earnings call highlighted strong financial performance, strategic priorities, and challenges in pediatric contracts and integration issues.
The company's focus on revenue optimization, leveraging technology, and partnership with Microsoft positions it well for growth opportunities within the customer base and offshoring initiatives.
While facing challenges in deal timings and debt repayment, R1 RCM Inc's emphasis on operational metrics, customer relationships, and workforce management presents avenues for continued success and industry leadership.

R1 RCM Inc reports robust Q4 earnings, eyes growth opportunities

R1 RCM Inc's Q4 2023 earnings call highlighted strong financial performance, strategic objectives for 2023, and a confident outlook for sustainable growth and shareholder value creation.
The company's emphasis on customer-centricity, AI integration, and operational efficiency underscores its strengths in revenue growth and market positioning.
While facing challenges in credit allowances and customer health, R1 RCM Inc aims to leverage opportunities in reduced costs, synergies from acquisitions, and strategic sales to drive future growth.

R1 RCM reports resilient Q1 performance post-cyberattack, eyes growth

R1 RCM showcased resilience in Q1 2024 despite the Change Healthcare cyberattack, focusing on growth strategies, operational excellence, and technology innovation.
The company faces challenges from the cyberattack impact on KPIs and vendor changes but sees opportunities in the managed care environment and customer engagement.
Overall, R1 RCM remains optimistic about transforming the industry through technology and expertise, with a strong market demand for its solutions.

R1 RCM Inc reports robust Q2 earnings amidst cyberattack challenges

R1 RCM Inc's Q2 2024 earnings call showcased strong financial performance, operational resilience in the face of cyberattacks, and a strategic focus on growth initiatives. The company faces challenges related to pending transactions and cyberattack impacts but sees opportunities in expanding its platform and leveraging technology for growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

R1 RCM serves as a revenue cycle management partner for hospitals and healthcare systems regardless of the payment models, patient engagement strategies, or settings of care. The company uses a proven operating model based on the R1 Performance StackSM designed to fit seamlessly into any healthcare organization’s infrastructure and to enhance the patient experience, improve provider economics, and provide revenue predictability. R1 RCM was founded on 2003 and is based in Chicago, Illinois.

MURRAY, Utah, Oct. 19, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended September 30, 2022, before market open on Tuesday, November 8, 2022.

R1 RCM to Release Third Quarter 2022 Results on November 8

Independent reports highlight today's top challenges and best practices during challenging financial times Independent reports highlight today's top challenges and best practices during challenging financial times

R1 RCM Releases Two Reports Focused on Improving Financial Outcomes and Driving Efficiency in Revenue Cycle Management

MURRAY, Utah, Sept. 08, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (“R1”) (NASDAQ: RCM) today announced the commencement of an underwritten public offering of 15,000,000 shares of its common stock by TCP-ASC ACHI Series LLLP (“TCP-ASC”), a Delaware series limited liability limited partnership jointly owned by Ascension Health Alliance and investment funds affiliated with TowerBrook Capital Partners L.P. R1 will not receive any of the proceeds from the sale of the shares being offered by the selling stockholder but will bear the costs associated with the sale of such shares, other than any underwriting discounts and commissions.

R1 Announces Offering of Common Stock by Selling Stockholder

MURRAY, Utah, Aug. 31, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the Baird 2022 Global Healthcare Conference on Wednesday, September 14, 2022, at 11:25 am ET.

R1 RCM to Present at the Baird 2022 Global Healthcare Conference

MURRAY, Utah , Aug. 31, 2022 /PRNewswire/ -- R1 RCM Inc. (NASDAQ: RCM) ("R1"), a leading provider of technology driven solutions that transform the patient experience and financial performance of healthcare providers, announced an agreement to be the exclusive provider of revenue cycle management services for Emergency Physicians Professional Association (EPPA), a physician group providing high-quality emergency medicine and urgent care across Minnesota. The partnership is expected to optimize clinical, financial, and operational performance for EPPA, while bolstering the patient experience and service for its patients.

R1 Announces RCM Partnership with Emergency Physicians Professional Association

MURRAY, Utah, Aug. 25, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), announced today a 10-year partnership with St. Clair Health to serve as its primary provider of end-to-end revenue cycle management (RCM) services.  St. Clair Health is a nationally recognized, integrated health system serving residents of Southwestern Pennsylvania. It is the parent organization of St. Clair Hospital; St. Clair Medical Group, a multispecialty group encompassing 150 primary and specialty care physicians; and a growing number of outpatient care locations across the region.

R1 RCM Announces 10-Year End-to-End Revenue Cycle Management Partnership with St. Clair Health

R1 RCM Inc. (NASDAQ:RCM ) Q2 2022 Earnings Conference Call August 3, 2022 8:00 AM ET Company Participants Atif Rahim - Head, Investor Relations Joseph Flanagan - President & Chief Executive Officer Lee Rivas - President Rachel Wilson - Executive Vice President, Chief Executive Officer & Treasurer Conference Call Participants Charles Rhyee - Cowen Glen Santangelo - Jefferies Stephanie Davis - SVB Leerink Anne Samuel - JPMorgan Jack Wallace - Guggenheim Securities Sean Dodge - RBC Capital Markets Operator Good morning, and welcome to the Q2 2022 R1 RCM Inc. Earnings Conference Call. All lines have been placed on mute to prevent any background noise.

R1 RCM Inc. (RCM) CEO Joseph Flanagan on Q2 2022 Results - Earnings Call Transcript

R1 RCM Inc. (RCM) delivered earnings and revenue surprises of 225% and 0.10%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

R1 RCM Inc. (RCM) Tops Q2 Earnings Estimates

MURRAY, Utah, Aug. 03, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended June 30, 2022.

R1 RCM Reports Second Quarter 2022 Results

The mean of analysts' price targets for R1 RCM Inc. (RCM) points to a 28.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Wall Street Analysts Think R1 RCM Inc. (RCM) Could Surge 28%: Read This Before Placing a Bet

R1 RCM Inc. (RCM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

R1 RCM Inc. (RCM) Earnings Expected to Grow: Should You Buy?

MURRAY, Utah, July 20, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended June 30, 2022 before market open on Wednesday, August 3, 2022.

R1 RCM to Release Second Quarter 2022 Results on August 3

R1 RCM's intra-quarter guidance update was net positive, with a downward revision for Q2 2022 offset by a stronger 2022/2023 outlook. Cloudmed equips RCM with a complete one-stop offering, further accelerating its growth outlook over the long run.

R1 RCM: Long-Term Growth Story Intact Following Cloudmed Acquisition

MURRAY, Utah, July 14, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, announced the execution of the 10-year agreement to be the exclusive provider of enterprise revenue cycle management services for Sutter Health, a not-for-profit integrated health system that provides high-quality care across Northern California.

R1 RCM Announces 10-Year End-to-End Revenue Cycle Management Partnership with Sutter Health to Drive Improved Financial Performance

MURRAY, Utah, June 21, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance for healthcare providers, today announced that it has granted equity awards under the R1 RCM Inc. 2022 Inducement Plan (the “Inducement Plan”) in connection with its acquisition of Cloudmed, which closed today.

R1 Announces Grants of Inducement Equity Awards in Connection with the Acquisition of Cloudmed

Combined company to deliver a scalable, flexible, and integrated platform to optimize revenue cycle and consumer engagement in healthcare

R1 RCM Completes Acquisition of Cloudmed

R1 RCM Inc. (NASDAQ:RCM ) Q1 2022 Earnings Conference Call May 9, 2022 8:00 AM ET Company Participants Atif Rahim - Head, Investor Relations Joe Flanagan - President & Chief Executive Officer Rachel Wilson - Executive Vice President, Chief Executive Officer & Treasurer Conference Call Participants Stephanie Davis - SVB Securities Sean Dodge - RBC Capital Markets Vikram Kesavabhotla - Baird Glen Santangelo - Jefferies Charles Rhyee - Cowen Jack Wallace - Guggenheim Partners George Hill - Deutsche Bank Operator Good morning. My name is Chris and I'll be your conference operator today.

R1 RCM Inc. (RCM) CEO Joe Flanagan on Q1 2022 Results - Earnings Call Transcript

R1 RCM Inc. (RCM) delivered earnings and revenue surprises of -10% and 0.42%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

R1 RCM Inc. (RCM) Lags Q1 Earnings and Revenue Estimates

MURRAY, Utah, May 09, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended March 31, 2022.

R1 RCM Reports First Quarter 2022 Results

MURRAY, Utah, May 09, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance for healthcare providers, and ScionHealth have entered into an agreement that will make R1 the exclusive provider of revenue cycle management (RCM) services for ScionHealth's 61 long-term acute care hospitals (LTACHs). Launched in December 2021, ScionHealth is a new health system comprised of 61 LTACHs previously owned by Kindred Healthcare and 18 short-term acute care community hospitals previously owned by LifePoint Health.

R1 Announces 10-Year End-to-End Revenue Cycle Management Partnership with ScionHealth

R1 RCM Inc. provides services to increase medical provider reimbursements and is an industry that grows at 10.3% annually. Changing regulations and the need to scale medical care across America will position R1 RCM Inc. to attract larger healthcare providers to its products and services.

R1 RCM: Undervalued Stock With 62.5% Upside

CEDARHURST, N.Y.--(BUSINESS WIRE)--Kuznicki Law PLLC is investigating the proposed sale of Cloudmed to R1 RCM Inc. (“the Company”) (NasdaqGS: RCM). Under the terms of the proposed transaction, Cloudmed equity holders will own approximately 30% of the combined company. Kuznicki Law is seeking to determine whether the merger and the process that led to it are adequate and fair to the Company's shareholders. If you would like to discuss your legal rights regarding the proposed sale, you may, witho

R1 RCM INVESTOR ALERT - Kuznicki Law PLLC Investigates R1 RCM Inc. - RCM

MoneyGram

Spirit Airlines

Zurn Water Solutions Corp

NEW YORK , April 26, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: R1 RCM Inc. (NASDAQ: RCM)'s merger with Cloudmed. Upon closing of the merger, R1 shareholders are expected to own approximately 70% of the combined company on a fully diluted basis while Cloudmed equity holders are expected to own approximately 30%.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates RCM, SAVE, ZWS, MGI

MURRAY, Utah, April 21, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended March 31, 2022 before market open on Monday, May 9, 2022.

R1 RCM to Release First Quarter 2022 Results on May 9

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Cloudmed to R1 RCM Inc. (“the Company”) (NasdaqGS: RCM). Under the terms of the proposed transaction, Cloudmed equity holders will own approximately 30% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate and fair to the Company's shareholders. If

News for R1 RCM Inc Stock (RCM)